We observed similar results in our cohort of depressed patients; a decrease in the severity of depression was assessed by the CDI score after 3 months administration of omega-3 FA (2.4 g/day) [24], a decrease in 8-IsoP-U and AOPP levels, and an increase in TEAC and SOD activity. This evidence concerns the gene SOD1 and depressive symptom measurement.